• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Claret Medical Inc.

Medicare might cover more cutting-edge medtech and pay more for it, too

July 30, 2019 By Nancy Crotti

The Centers for Medicare and Medicaid Services (CMS) said today it wants to give Medicare patients better access to cutting-edge medical devices, and that it’s willing to pay more for them beginning in fiscal year 2020. In its proposed rule, CMS said it might pay more for “certain transformative new devices” for inpatients through a […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Medicare, News Well, Regulatory/Compliance Tagged With: Boston Scientific, Centers for Medicare and Medicaid Services (CMS), CivaTech Oncology Inc., Claret Medical Inc., FDA, GT Medical Technologies, IsoRay, Johnson and Johnson, Procept BioRobotics, Respicardia, TherOx Inc, Zoll Medical

Boston Scientific closes $270m Claret Medical buy

August 3, 2018 By Brad Perriello

Boston Scientific (NYSE:BSX) said yesterday that it closed the $270 million buyout of Claret Medical and its Sentinel device, including a $50 million earnout pegged to a reimbursement win that just came in. Claret’s Sentinel device is designed to trap and remove debris dislodged during transcatheter aortic valve replacements to prevent stroke and other neurological damage. The deal, announced […]

Filed Under: Mergers & Acquisitions, Replacement Heart Valves, Wall Street Beat Tagged With: Boston Scientific, Claret Medical Inc.

Boston Scientific puts $270m on the table for Claret Medical

July 20, 2018 By Brad Perriello

Boston Scientific (NYSE:BSX) said today that it agreed to pay as much as $270 million to acquire Claret Medical and its Sentinel device. Marlborough, Mass.-based Boston Scientific said the deal involves an up-front cash payment of $220 million and another $50 million pegged to a reimbursement milestone. Claret’s Sentinel device is designed to trap and remove […]

Filed Under: Mergers & Acquisitions, Replacement Heart Valves, Wall Street Beat Tagged With: Boston Scientific, Claret Medical Inc.

Report: Extra insights, but no clear-cut answers from TAVR embolic protection studies

May 31, 2018 By Fink Densford

Data from two new studies has provided extra insights, but no clear-cut solution for predicting stroke and which patients should receive embolic protection devices during transcatheter aortic valve replacement procedures, according to a new Medscape report. Results from a meta-analysis of 1,285 patients indicated that the use of embolic protection devices during TAVR procedures did […]

Filed Under: Cardiovascular, Catheters, Clinical Trials, Vascular Tagged With: Claret Medical Inc.

Claret Medical raises $21m to support Sentinel system

October 23, 2017 By Fink Densford

Claret Medical has raised $21.2 million in a new round of equity financing, according to an SEC filing posted last week. In a press release posted today, the company said that it raised $14.5 million in a Series C round led by Lightstone Ventures and joined by Easton Capital, HealthCor Partners, Incept and Sante Ventures. […]

Filed Under: Business/Financial News Tagged With: Claret Medical Inc.

Claret Medical touts Sentinel data in TAVR study

September 18, 2017 By Fink Densford

Claret Medical today released results from a study of its Sentinel cerebral protection system, touting reduced early occurrence of stroke associated with transcatheter aortic valve replacement procedures and lowered mortality rates. The study of the device was recently published in the Journal of the American College of Cardiology: Cardiovascular Interventions, the Santa Rosa, Calif.-based company said. […]

Filed Under: Cardiovascular, Catheters, Clinical Trials, Neurological Tagged With: Claret Medical Inc.

Claret Medical raises $11m

July 17, 2017 By Fink Densford

Claret Medical has raised $11.2 million in a new round of equity financing, according to an SEC filing posted this week. Money in the round came from 34 unnamed investors, according to the SEC filing, with the 1st sale dated on June 22. Claret Medical is still looking to raise an additional $6.5 million in […]

Filed Under: Business/Financial News Tagged With: Claret Medical Inc.

MassDevice Q&A: Claret Medical’s Azin Parhizgar on trying to make TAVR safer

June 12, 2017 By Fink Densford

Cerebral protection developer Claret Medical recently won FDA de novo clearance for its Sentinel device designed to trap blood clots and prevent stroke during heart valve replacement procedures. The Sentinel uses a pair of filters, 1 in the brachiocephalic artery another in the left common carotid artery, to trap debris released during transcatheter aortic valve replacement that could cause […]

Filed Under: Neurological, Surgical, Vascular Tagged With: Claret Medical Inc.

Claret Medical wins de novo FDA nod for Sentinel TAVR filter

June 5, 2017 By Brad Perriello

Claret Medical said today that the FDA granted de novo clearance for its Sentinel device, which is designed to trap blood clots before they reach the brain during heart valve replacement procedures. The Sentinel uses a pair of filters, 1 in the brachiocephalic artery another in the left common carotid artery, to trap debris released during transcatheter aortic […]

Filed Under: Cardiovascular, Food & Drug Administration (FDA), Regulatory/Compliance, Replacement Heart Valves, Wall Street Beat Tagged With: Claret Medical Inc., De Novo Clearance

FDA panel supports Claret Medical’s Sentinel, despite efficacy questions

February 24, 2017 By Fink Densford

UPDATED Feb. 27, 2017, with reaction from Claret Medical. The FDA’s Circulatory System Devices Panel this week gave its support to de novo clearance for Claret Medical’s Sentinel embolic protection device despite weak efficacy data for the device. The Santa Rosa, Calif.-based company’s Sentinel device is designed to use a pair of temporary arterial filters during […]

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance, Replacement Heart Valves, Vascular Tagged With: Claret Medical Inc.

Claret Medical wins a date with the FDA for Sentinel TAVR device

January 10, 2017 By Brad Perriello

An FDA advisory panel is slated to review next month the Sentinel embolic protection device made by Claret Medical, following the company’s bid for de novo clearance last fall. The federal watchdog’s Circulatory System Devices Panel scheduled a hearing for Feb. 23 to review the clearance bid for Sentinel, which is designed to use a pair of […]

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance, Replacement Heart Valves Tagged With: Claret Medical Inc.

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS